On the CV risk side, we have many biochemical markers (hyperandrogenism, estrogen/progesterone imbalance, IR, compensatory hyperinsulinemia, and low SHBG) which tell us that PCOS should be regarded as a high-risk state, while minimal CV event data show us inconclusive results. This evidence concerns the gene SHBG and polycystic ovary syndrome.